The University of Alabama at Birmingham (UAB) received a $220,326 Project Grant award under the Department of Defense's Military Medical Research and Development Program (CFDA 12.420). The grant, awarded on April 1, 2025, supports the development of novel, selective PARP protein degraders for prostate cancer treatment utilizing PSMA uptake enhancement. This research aims to transform healthcare for military service members and the broader public through innovative and impactful medical solutions. The grant will enable UAB to conduct basic, applied, and advanced biomedical research to investigate novel therapeutic approaches for prostate cancer, a critical health challenge facing the military population. The project is scheduled for completion by March 31, 2027.
Generated 3/18/25, 3:09 AM